MUM1 and BCL6 but not HGAL are independent prognostic indicators of outcome in nodal diffuse large B-Cell lymphoma

被引：0
|
作者：
Wongchaowart, NT
Segota, E
Pohlman, B
Lossos, IS
Natkunam, Y
Levy, R
Jin, T
Hsi, ED
机构：
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[2] Univ Miami, Miami, FL 33152 USA
[3] Stanford Univ, Sch Med, Stanford, CA 94305 USA
来源：
LABORATORY INVESTIGATION | 2006年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1167
引用
收藏
页码：252A / 252A
页数：1
相关论文
共 50 条
  • [21] Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements
    Frauenfeld, Leonie
    Castrejon-de-Anta, Natalia
    Enric Ramis-Zaldivar, Joan
    Streich, Sebastian
    Salmeron-Villalobos, Julia
    Otto, Franziska
    Mayer, Annika Katharina
    Steinhilber, Julia
    Pinyol, Magda
    Mankel, Barbara
    Ramsower, Colleen
    Bonzheim, Irina
    Fend, Falko
    Rimsza, Lisa M.
    Salaverria, Itziar
    Campo, Elias
    Balague, Olga
    Quintanilla-Martinez, Leticia
    BLOOD ADVANCES, 2022, 6 (07) : 2361 - 2372
  • [22] MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
    Horn, Heike
    Ziepert, Marita
    Becher, Claudia
    Barth, Thomas F. E.
    Bernd, Heinz-Wolfram
    Feller, Alfred C.
    Klapper, Wolfram
    Hummel, Michael
    Stein, Harald
    Hansmann, Martin-Leo
    Schmelter, Christopher
    Moeller, Peter
    Cogliatti, Sergio
    Pfreundschuh, Michael
    Schmitz, Norbert
    Truemper, Lorenz
    Siebert, Reiner
    Loeffler, Markus
    Rosenwald, Andreas
    Ott, German
    BLOOD, 2013, 121 (12) : 2253 - 2263
  • [23] Prognostic significance of BCL6 and BCL2 expression in diffuse large B cell lymphoma (DLBCL)
    Dominic, Joseph F.
    Sharma, Atul
    Sharma, M. C.
    Karak, A. K.
    Kochupillai, Vinod
    Kalaivani, M.
    ANNALS OF ONCOLOGY, 2006, 17 : 201 - 201
  • [24] Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma
    Ye, Qing
    Xu-Monette, Zijun Y.
    Tzankov, Alexandar
    Deng, Lijuan
    Wang, Xiaoxiao
    Manyam, Ganiraju C.
    Visco, Carlo
    Montes-Moreno, Santiago
    Zhang, Li
    Dybkaer, Karen
    Chiu, April
    Orazi, Attilio
    Zu, Youli
    Bhagat, Govind
    Richards, Kristy L.
    Hsi, Eric D.
    Choi, William W. L.
    van Krieken, J. Han
    Huh, Jooryung
    Ponzoni, Maurilio
    Ferreri, Andres J. M.
    Parsons, Ben M.
    Moller, Michael B.
    Piris, Miguel A.
    Winter, Jane N.
    Medeiros, L. Jeffrey
    Hu, Shimin
    Young, Ken H.
    ONCOTARGET, 2016, 7 (03) : 2401 - 2416
  • [25] Prognostic Significance of BCL6 Translocation in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP.
    Shustik, Jesse
    Steidl, Christian
    Selm, Laurie
    Gascoyne, Randy D.
    BLOOD, 2008, 112 (11) : 1294 - 1295
  • [26] High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology
    Scott, David W.
    King, Rebecca L.
    Staiger, Annette M.
    Ben-Neriah, Susana
    Jiang, Aixiang
    Horn, Heike
    Mottok, Anja
    Farinha, Pedro
    Slack, Graham W.
    Ennishi, Daisuke
    Schmitz, Norbert
    Pfreundschuh, Michael
    Nowakowski, Grzegorz S.
    Kahl, Brad S.
    Connors, Joseph M.
    Gascoyne, Randy D.
    Ott, German
    Macon, William R.
    Rosenwald, Andreas
    BLOOD, 2018, 131 (18) : 2060 - 2064
  • [27] PDL1 and MUM1 Expression Are Associated with Outcome in Primary Mediastinal Large B-cell Lymphoma
    Bledsoe, Jacob
    Redd, Robert
    Zukerberg, Lawrence
    Abramson, Jeremy
    Sohani, Aliyah R.
    LABORATORY INVESTIGATION, 2016, 96 : 336A - 337A
  • [28] Expression of MUM1/IRF4 correlates with prognosis in patients with diffuse large B-cell lymphoma
    Trzpuc, T
    Kampalath, B
    Abed, N
    Shidham, V
    Rao, A
    Nagargoje, G
    Chang, C
    LABORATORY INVESTIGATION, 2002, 82 (01) : 267A - 267A
  • [29] Expression of MUM1/IRF4 correlates with prognosis in patients with diffuse large B-cell lymphoma
    Trzpuc, T
    Kampalath, B
    Abed, N
    Shidham, V
    Rao, A
    Nagargoje, G
    Chang, C
    MODERN PATHOLOGY, 2002, 15 (01) : 267A - 267A
  • [30] Prognostic implications of BCL6 rearrangement in uniformly treated patients with diffuse large B-cell lymphoma -: A Nordic Lymphoma Group study
    Jerkeman, M
    Åman, P
    Cavallin-Stahl, E
    Torlakovic, E
    Åkerman, M
    Mitelman, F
    Fioretos, T
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2002, 20 (01) : 161 - 165
12345